Charlotte Sagne

903 citations
5 papers · 472 indexed · h-index 5
    • Cancer-related Molecular Pathways 3
    • PARP inhibition in cancer therapy 1
    • Cancer Research and Treatments 2
    • RNA Interference and Gene Delivery 1
    • RNA modifications and cancer 1
    • DNA and Nucleic Acid Chemistry 1
    • DNA Repair Mechanisms 1
    • Virus-based gene therapy research 1

Charlotte Sagne

5 papers receiving 467 citations

Peers

Charlotte Sagne
Comparison fields: 5 of 58
  • Oncology 213
  • Biotechnology 51
  • Molecular Biology 365
  • Cancer Research 77
  • Aging 3
Replace Sebastien M. Joruiz with:
Sebastien M. Joruiz United States
Sally Turla United States
Rasa Beinoravičiūtė-Kellner Germany
Amir Zalcenstein Israel
Seong-Jun Cho United States
Sofia Henriksson Sweden
Crystal A. Tonnessen-Murray United States
Helen Clayton United Kingdom
Ying-Hui Zhu China
Charlotte Sagne relative to Sebastien M. Joruiz United States Sebastien M. Joruiz's profile →
Citations per field
00.5×3.4×
Sebastien M. Joruiz · 1×
Citations per year

Countries citing papers authored by Charlotte Sagne

Since Specialization
Citations

This map shows the geographic impact of Charlotte Sagne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte Sagne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte Sagne more than expected).

Fields of papers citing papers by Charlotte Sagne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte Sagne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte Sagne. The network helps show where Charlotte Sagne may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Charlotte Sagne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Charlotte Sagne Line = papers co-authored together Charlotte Sagne links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown

About Charlotte Sagne

Charlotte Sagne is a scholar working on Biotechnology, Oncology and Molecular Biology, having authored 5 papers that have together received 472 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (3 papers), Cancer Research and Treatments (2 papers), RNA Interference and Gene Delivery (1 paper), RNA modifications and cancer (1 paper), Virus-based gene therapy research (1 paper), DNA and Nucleic Acid Chemistry (1 paper), DNA Repair Mechanisms (1 paper) and PARP inhibition in cancer therapy (1 paper). The work is most often cited by research in Oncology (213 citations), Biotechnology (51 citations) and Molecular Biology (365 citations). Charlotte Sagne has collaborated with scholars based in France, United Kingdom and Luxembourg. Frequent co-authors include Pierre Hainaut, Virginie Marcel, Magali Olivier, Janet Hall, Hind Hafsi, J. Hall, Phong Lan Thao Tran, Ghyslaine Martel‐Planche, Eric Van Dyck and Jean‐Louis Mergny. Their work appears in journals such as Carcinogenesis, Oncogene, Cell Death and Disease, Cell Death and Differentiation and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026